Alcohol Consumption and the Risk of Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis

American Journal of Ophthalmology

Volumn 145, Issue 4, 2008, Pages

  Chong, Elaine W T ^a   Kreis, Andreas J ^a   Wong, Tien Y ^a,b   Simpson, Julie A ^a,c   Guymer, Robyn H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; DATA ANALYSIS; DOSE RESPONSE; HUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS;

EID: 40849119734     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.12.005     Document Type: Article

References (61)

1. Bressler N.M. Age-related macular degeneration is the leading cause of blindness. JAMA 291 (2004) 1900-1901
2. VanNewkirk M.R., Nanjan M.B., Wang J.J., Mitchell P., Taylor H.R., and McCarty C.A. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 107 (2000) 1593-1600
3. Friedman D.S., O'Colmain B.J., Munoz B., et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
4. Owen C.G., Fletcher A.E., Donoghue M., and Rudnicka A.R. How big is the burden of visual loss caused by age-related macular degeneration in the United Kingdom?. Br J Ophthalmol 87 (2003) 312-317
5. Mitchell P., Smith W., Attebo K., and Wang J.J. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102 (1995) 1450-1460
6. Klein R., Klein B.E., and Linton K.L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99 (1992) 933-943
7. Arroyo J.G. A 76-year-old man with macular degeneration. JAMA 295 (2006) 2394-2406
8. Haines J.L., Hauser M.A., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
9. Baird P.N., Richardson A.J., Robman L.D., et al. Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD). Hum Mutat 27 (2006) 337-342
10. Thornton J., Edwards R., Mitchell P., Harrison R.A., Buchan I., and Kelly S.P. Smoking and age-related macular degeneration: a review of association. Eye 19 (2005) 935-944
11. Christen W.G., Glynn R.J., Manson J.E., Ajani U.A., and Buring J.E. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 276 (1996) 1147-1151
12. Seddon J.M., Willett W.C., Speizer F.E., and Hankinson S.E. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 276 (1996) 1141-1146
13. Gragoudas E.S., Adamis A.P., Cunningham Jr. E.T., Feinsod M., and Guyer D.R. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
14. Rosenfeld P.J., Brown D.M., Heier J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
15. Brown D.M., Kaiser P.K., Michels M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1432-1444
16. Snow K.K., and Seddon J.M. Do age-related macular degeneration and cardiovascular disease share common antecedents?. Ophthalmic Epidemiol 6 (1999) 125-143
17. Chaine G., Hullo A., Sahel J., et al. Case-control study of the risk factors for age-related macular degeneration. France-DMLA Study Group. Br J Ophthalmol 82 (1998) 996-1002
18. Hyman L.G., Lilienfeld A.M., Ferris III F.L., and Fine S.L. Senile macular degeneration: a case-control study. Am J Epidemiol 118 (1983) 213-227
19. Mukamal K.J., Conigrave K.M., Mittleman M.A., et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 348 (2003) 109-118
20. Rimm E.B., Klatsky A., Grobbee D., and Stampfer M.J. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ 312 (1996) 731-736
21. Stampfer M.J., Colditz G.A., Willett W.C., Speizer F.E., and Hennekens C.H. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 319 (1988) 267-273
22. Agar E., Demir S., Amanvermez R., Bosnak M., Ayyildiz M., and Celik C. The effects of ethanol consumption on the lipid peroxidation and glutathione levels in the right and left brains of rats. Int J Neurosci 113 (2003) 1643-1652
23. Cederbaum A.I. Role of lipid peroxidation and oxidative stress in alcohol toxicity. Free Radic Biol Med 7 (1989) 537-539
24. Jakubowski J.A., Vaillancourt R., and Deykin D. Interaction of ethanol, prostacyclin, and aspirin in determining human platelet reactivity in vitro. Arteriosclerosis 8 (1988) 436-441
25. Hendriks H.F., Veenstra J., Velthuis-te Wierik E.J., Schaafsma G., and Kluft C. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. BMJ 308 (1994) 1003-1006
26. Ridker P.M., Vaughan D.E., Stampfer M.J., Glynn R.J., and Hennekens C.H. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 272 (1994) 929-933
27. Albert M.A., Glynn R.J., and Ridker P.M. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 107 (2003) 443-447
28. Levitan E.B., Ridker P.M., Manson J.E., et al. Association between consumption of beer, wine, and liquor and plasma concentration of high-sensitivity C-reactive protein in women aged 39 to 89 years. Am J Cardiol 96 (2005) 83-88
29. Castelli W.P., Doyle J.T., Gordon T., et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet 2 (1977) 153-155
30. Rimm E.B., Williams P., Fosher K., Criqui M., and Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319 (1999) 1523-1528
31. Smith W., Mitchell P., Leeder S.R., and Wang J.J. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 116 (1998) 583-587
32. Vingerling J.R., Dielemans I., Bots M.L., Hofman A., Grobbee D.E., and de Jong P.T. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 142 (1995) 404-409
33. Stewart S.H. Alcohol and inflammation: a possible mechanism for protection against ischemic heart disease. Nutr Metab Cardiovasc Dis 12 (2002) 148-151
34. Seddon J.M., Gensler G., Milton R.C., Klein M.L., and Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 291 (2004) 704-710
35. National Institutes of Health. Clinical Trials Database. http://clinicaltrials.gov Accessed Date: November 25, 2007
36. Bird A.C., Bressler N.M., Bressler S.B., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39 (1995) 367-374
37. Klein R., Davis M.D., Magli Y.L., Segal P., Klein B.E., and Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 98 (1991) 1128-1134
38. NHMRC. Evidence regarding the level of alcohol consumption considered to be low-risk for men and women (2000). http://www.nhmrc.gov.au/publications/synopses/_files/alc-comp.pdf Accessed Date: November 25, 2007
39. Dufour M.C. What is moderate drinking?. Defining "drinks" and drinking levels. Alcohol Res Health 23 (1999) 5-14
40. NHMRC. Australian Alcohol Guidelines, Health Risks and Benefits. Guidelines for the Whole Population (2001). http://www.nhmrc.gov.au/publications/_files/ds9.pdf Accessed Date: November 25, 2007
41. McAuley L., Pham B., Tugwell P., and Moher D. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?. Lancet 356 (2000) 1228-1231
42. Downs S.H., and Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomized studies of health care interventions. J Epidemiol Community Health 52 (1998) 377-784
43. Deeks J.J., Dinnes J., D'Amico R., et al. Evaluating non-randomized intervention studies. Health Technol Assess 7 (2003) iii-x 1-173
44. Bagnardi V., Zambon A., Quatto P., and Corrao G. Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol 159 (2004) 1077-1086
45. Cochrane Collaboration. Review Manager. http://www.cc-ims.net/RevMan Accessed Date: November 25, 2007
46. Higgins J.P., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
47. Sterne J.A., and Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54 (2001) 1046-1055
48. Knudtson M.D., Klein R., and Klein B.E. Alcohol consumption and the 15-year cumulative incidence of age-related macular degeneration. Am J Ophthalmol 143 (2007) 1026-1029
49. Buch H., Vinding T., la Cour M., Jensen G.B., Prause J.U., and Nielsen N.V. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmol Scand 83 (2005) 409-418
50. Cho E., Hankinson S.E., Willett W.C., et al. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol 118 (2000) 681-688
51. Ajani U.A., Christen W.G., Manson J.E., et al. A prospective study of alcohol consumption and the risk of age-related macular degeneration. Ann Epidemiol 9 (1999) 172-177
52. Arnarsson A., Sverrisson T., Stefansson E., et al. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. Am J Ophthalmol 142 (2006) 419-428
53. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
54. Katz M.L., Parker K.R., Handelman G.J., Bramel T.L., and Dratz E.A. Effects of antioxidant nutrient deficiency on the retina and retinal pigment epithelium of albino rats: a light and electron microscopic study. Exp Eye Res 34 (1982) 339-369
55. A randomized placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch Ophthalmol 119 (2001) 1417-1436
56. Brady W.E., Mares-Perlman J.A., Bowen P., and Stacewicz-Sapuntzakis M. Human serum carotenoid concentrations are related to physiologic and lifestyle factors. J Nutr 126 (1996) 129-137
57. Bora P.S., Kaliappan S., Xu Q., et al. Alcohol linked to enhanced angiogenesis in rat model of choroidal neovascularization. FEBS J 273 (2006) 1403-1414
58. Dickersin K. Systematic reviews in epidemiology: why are we so far behind?. Int J Epidemiol 31 (2002) 6-12
59. Egger M., Schneider M., and Davey Smith G. Spurious precision?. Meta-analysis of observational studies. BMJ 316 (1998) 140-144
60. Klein R., Klein B.E.K., Tomany S.C., and Moss S.E. Ten-year incidence of age-related maculopathy and smoking and drinking. The Beaver Dam Eye Study. Am J Epidemiol 156 (2002) 589-598
61. Goldberg I.J., Mosca L., Piano M.R., and Fisher E.A. AHA Science Advisory: Wine and your heart: a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation 103 (2001) 472-475